期刊文献+

维持性血液透析患者钙磷代谢特点分析 被引量:3

下载PDF
导出
摘要 维持性血液透析(MHD)是目前治疗终末期肾衰的主要手段,能显著提高患者生活质量,延长寿命,但其仍存在较多远期并发症。心血管疾病是MHD患者的常见并发症及主要死亡原因。血管钙化是预测MHD患者心血管并发症发生的重要指标,钙磷代谢紊乱与血管钙化密切相关。透析预后与实践模式研究(DOPPS)显示透析患者血清校正Ca、P、i PTH异常发生率高,且达标率普遍偏低,我国现况更严峻。
作者 魏丽 魏崇一
出处 《中国现代医药杂志》 2016年第2期53-55,共3页 Modern Medicine Journal of China
  • 相关文献

参考文献9

  • 1Bernuy J,Gonzales GF. Bone mineral metabolism in patients with chronic kidney disease: Review of its pathophysiology and mor- bimortality[J]. Rev Peru Med Exp Salud Publiea, 2015,32 (2) : 326-334.
  • 2Hanafusa N.Vaseular Caleifieation-Pathologieal Meehanism andClinical Application-. The effect of phosphate binders on vascu- lar calcification[J].Clin Calcium, 2015,25 (5) : 711-721.
  • 3杨福燕,庞家亮,魏崇一.维持性血液透析患者矿物质代谢研究[J].国际移植与血液净化杂志,2014,12(3):13-16. 被引量:4
  • 4Babayev R, Nickolas TL. Bone Disorders in Chronic Kidney Dis- ease:An Update in Diagnosis and Management [J]. Semin Dial, 2015,28(6) :645-653.
  • 5Adhikary LP,Yadava SK,Pokharel A,et al. Relation between Cal- cium ,Phosphorus ,Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients[J]. J Nepal Health Res Counc,2015,13 (29) :50-53.
  • 6Bover J,Evenepoel P,Urefia-Torres P,et al. CKD-MBD Working Group of ERA-EDTA.Pro: Cardiovascular calcifications are clin-.ically relevant[J].Nephrol Dial Transplant, 2015,30(3 ) : 345-351.
  • 7D'Alessandro C ,Piccoli GB ,Cupisti A. The "phosphorus pyra- mid" :a visual tool for dietary phosphate management in dialysis and C KD patients[J].BMC Nephrol, 2015,20 : 16-19.
  • 8Streja E,Wang HY,Lau WL,et al. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients [J].Bone,2014,61: 201-207.
  • 9Karkar A,Sinha AK,Abdelrahman M,et al.Trends of elevated parathormoue serum titers in hemodialysis patients on intensive therapy for bone disease: a muhicenter study[J]. Saudi J Kidney Dis Transp1,2014,25 (6) : 1166-1177.

二级参考文献20

  • 1Levin A,Bakris GL,Molitch M. Prevalence of abnormal serum vitamin D,PTH,calcium and phosphorus in patients with chronic kidney disease:results of the study to evaluate early kidney disease[J].Kidney International,2007.31-38.
  • 2Kidney Disease Improving Global Outcome (KDIGO) CKDMBD Work Group. KDIGO clinical practice guideline for the diagnosis evaluation,prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J].Kidney International Supplement,2009.S1-130.
  • 3Kendric J,Chonchol M. The role of phosphorus in the development and progression of vascular calcification[J].American Journal of Kidney Disease,2011.826-834.
  • 4Adeney KL,Siscovic DS,Ix JH. Association of serum phosphate with vascular and valvular calcification in moderate CKD[J].Journal of the American Society of Nephrology,2009.381-387.
  • 5Kong X,Zhang L,Zhang L. Mineral and bone disorder in Chinese dialysis patients:a multicenter study[J].BMC Nephrology,2012.116.
  • 6Palmer SC,Hayen A,Macaskill P. Serum levels of phosphorus,parathyroid hormone,and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease:a systematic review and meta-analysis[J].JAMA:the Journal of the American Medical Association,2011.1119-1127.
  • 7Isakova T,Gutiérrez OM,Chang Y. Phosphorus binders and survival on hemodialysis[J].Journal of the American Society of Nephrology,2009.388-396.
  • 8Zimmerman DL,Nesrallah GE,Chan CT. Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis:a systematic review and metaanalysis for a Canadian Society of nephrology clinical practice guideline[J].American Journal of Kidney Disease,2013.97-111.
  • 9Blayney MJ,Pisoni RL,Bragg-Gresham JL. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death[J].Kidney International,2008.655-663.
  • 10Drechsler C,Verduijn M,Pilz S. Bone alkaline phosphatase and mortality in dialysis patients[J].Clin J Am Soc Nephrol,2011.1752-1759.

共引文献3

同被引文献20

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部